Antibiotics are used for a variety of purposes in
the husbandry of livestock, including therapeutic (treatment when
ill), curing a batch of animals when a minimum of one among the group
is diagnosed ill (metaphylaxis, it is similar to the method bacterial
meningitis is managed in children), and prophylaxis or preventative
treatment against a number of diseases. The employment of
sub-therapeutic doses in water and/or animal feed to develop feed
efficiency and encourage growth was eliminated altogether effective
January 1, 2017, as per the new FDA Veterinary Feed Directive.
Antimicrobials (including antifungals and antibiotics) and other
types of drugs are used by livestock owners and veterinarians in the
U.S. for control, treatment, or prevention of livestock diseases.
Some of the countries outside North America and Europe can administer
antimicrobials to augment the development rates of poultry,
livestock, and other farmed animals, even though these drugs do not
mandatorily have to be used by a veterinarian. The term animal
antimicrobial or antibiotic is usually used for those agents who
inhibit or kill the growth of microorganism in animals especially
livestock.
Fill the form for an exclusive sample of this
report :
https://www.coherentmarketinsights.com/insight/request-sample/522
The rising demand for livestock products, owing to
increasing population of livestock throughout the world is likely to
boost growth of the animal antimicrobials and antibiotics market.
Moreover, the rising incidence of diseases in livestock is likely to
aid in the expansion of this market. However, the use of in-feed
enzymes and stringent regulations are limiting the growth of this
market. Another factor boosting the overall growth of the market is
the growing demand for animal proteins and the increasing trend of
pet ownership. The growing incidences of animal disease epidemics,
rising population of livestock and favorable economic conditions of
emerging economies including China, Brazil, and India, are
encouraging the growth of this market.
On the other hand, some factors including the
augmented administration of in-feed enzymes, firm regulatory policies
in the field and increased use of substitute medicines including
prebiotics are likely to restrain the growth of the overall animal
antimicrobials and antibiotics market during the forecast period.
Animal antimicrobials and antibiotics
market Taxonomy
On the basis of type of product,
-
Penicillin
-
Tetracycline
-
Sulfonamides
-
Quinolones
-
Macrolides
-
Cephalosporin
-
Amingoglycoside
-
Others
On the basis of type of animals,
-
Companion animals
-
Food-producing animals
On the basis of mode of delivery,
-
Oral powder or solutions
-
Injections
-
Premix
-
Others
High growth of livestock and increased
consumption of milk and other food products will drive the overall
animal antimicrobials and antibiotics market
The antimicrobial and antibiotic products have
considerable benefits to the animal as well as to human food safety.
Researchers have shown that a rise in the rate of animal illness
invariably results into higher rate of illness among humans. Hence,
livestock traders depend primarily on animal antibiotics to offer
safe food. Another factor driving the market is the rising demand for
meat, milk, and other animal food products. The profound usage of
various types of meats and a variety of milk in the dairy products,
especially in the western diet and the speedy adoption of these
eating habits across the globe are expected to lead to a rise in
demand for animal antimicrobials and antibiotics around the globe.
These factors will fuel the growth of the animal antimicrobials and
antibiotics market in the near future.
On the basis of geography, North America held the
largest share of the animal antibiotics and antimicrobials market.
This dominance can be attributed to the developed animal healthcare
market in this region. Other factors driving the market in this
region are growing demand for animal-derivative food products,
increasing expenditure on animal healthcare, rising animal
population, and increase in awareness about the zoonotic diseases
(disease transmitted from animals to humans). Nonetheless, the
Asia-Pacific market is likely to grow at the maximum CAGR, due to
rising animal population, growing demand for animal based food
products, rise in awareness about animal welfare and animal health,
especially in the emerging economies of China and India.
Request for table of content :
https://www.coherentmarketinsights.com/ongoing-insight/toc/522
The key market players operating in the global
animal antimicrobials and antibiotics market are Merck & Co.,
Inc., Zoetis, Inc., Bayer AG, Virbac, Eli Lilly Company, Boehringer
Ingelheim GmbH, Vetoquinol S.A., Ceva Sante Animale, Dechra
Pharmaceuticals PLC and Sanofi.
About Coherent Market Insights:
Coherent Market Insights is a
prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations
related to emerging market trends, technologies, and potential
absolute dollar opportunity
No comments:
Post a Comment